FDA gives AstraZeneca the thumbs-up to restart PhIII Covid-19 vaccine trials, and J&J is preparing to resume its study

Max Gelman

Senior Editor

Several countries had restarted their portions of AstraZeneca’s global Phase III Covid-19 vaccine trial after the study was paused worldwide in early September, but …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

FDA gives AstraZeneca the thumbs-up to restart PhIII Covid-19 vaccine trials, and J&J is preparing to resume its study

Max Gelman

Senior Editor

Sign up to read this article for free.

Post-Hoc: RFK vs. Vivek, and the future of US drug policy

Boston Pharmaceuticals hits Phase 2 goals as it tries to keep up with MASH competitors

ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap

Evotec gains on Halozyme's takeover proposal

Arc Institute publishes new AI model Evo, creating CRISPR systems in a leap for synthetic biology

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?

FDA gives As­traZeneca the thumbs-up to restart PhI­II Covid-19 vac­cine tri­als, and J&J is prepar­ing to re­sume its study

Max Gelman

Senior Editor

Sign up to read this article for free.

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

Boston Phar­ma­ceu­ti­cals hits Phase 2 goals as it tries to keep up with MASH com­peti­tors

ALX On­col­o­gy hires Genen­tech, Mi­rati vet as CMO; Af­ter Car­mot, Heather Turn­er has three new roles on tap

Evotec gains on Halozyme's takeover pro­pos­al

Arc In­sti­tute pub­lish­es new AI mod­el Evo, cre­at­ing CRISPR sys­tems in a leap for syn­thet­ic bi­ol­o­gy

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

FDA gives AstraZeneca the thumbs-up to restart PhIII Covid-19 vaccine trials, and J&J is preparing to resume its study

Post-Hoc: RFK vs. Vivek, and the future of US drug policy

Boston Pharmaceuticals hits Phase 2 goals as it tries to keep up with MASH competitors

ALX Oncology hires Genentech, Mirati vet as CMO; After Carmot, Heather Turner has three new roles on tap

Evotec gains on Halozyme's takeover proposal

Arc Institute publishes new AI model Evo, creating CRISPR systems in a leap for synthetic biology

What Will It Take to Reverse Fibrosis in Patients with Advanced MASH?